Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Second Quarter and Half Year ended September 30, 2013 on Thursday, October 31, 2013 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com

Summary of Events
         
Event   Date and Time (IST)   Medium
Release of financial results   October 31st, after the Board Meeting  

Email, Media, Company website, Business Wire
Earnings Call   October 31st, 6.30 PM IST / 9:00 AM EDT   Hosted by the Company

(Details below)
Webcast of Earnings Call   October 31st, 6.30 PM IST / 9.00 AM EDT through November 5th, 2013  

URL available on Company’s website, www.drreddys.com
Transcripts of the Earnings call   Will be available on the Company’s website  

URL available on Company’s website, www.drreddys.com
   

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.
 
Conference Dial-In Numbers
Primary Number:   +91 22 6629 0356
Secondary Number:   +91 22 3065 0136
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number:  

6000 1221Available in - Ahmedabad, Bangalore, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi, Goa, Guntur, Gurgaon, Hyderabad, Indore, Jamshedpur, Kanpur, Kochi/Cochin, Kolhapur, Kolkata, Nagpur, Noida, Patna, Pune, Raipur, Rajkot, Surat, Trivandrum, Vadodara, VijayawadaAccessible from all major carriers except BSNL/MTNL.3940 3977Available in Ahmedabad, Bangalore, Chandigarh, Chennai, Kochi/Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, PuneAccessible from all carriers.
International Toll Free Number:  

USA: 1 866 746 2133UK: 0 808 101 1573Singapore: 800 101 2045Hong Kong: 800 964 448
 

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through October 5th, 2013. For play back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's website.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets.

For more information, log on to: www.drreddys.com

*EDT- Eastern Daylight Saving Time

Copyright Business Wire 2010